Jeffrey L. Ives, Director at Cara Therapeutics, Inc. (CARA), sold 2,500 shares at $20.68 ($52K) on 2019-11-01, disclosed to the SEC on 2019-11-05.
Open-market sale of $52k CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CARA | SELL | 2021-11-16 | $262K | — | Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |